| Screening | Pre-treatment | Mid-treatment | Post-treatment | 3-month follow-up |
---|
Screening measures |
 Demographics | + |  |  |  |  |
 Risk questionnaire | + |  |  |  |  |
 DIAMOND screener | + |  |  |  |  |
 DIAMOND Interview | + |  |  | + | + |
 C-SSRS | + |  |  |  |  |
Primary outcome measure |
 GAD-7 |  | + | + | + | + |
Secondary outcome measures |
 GAD-D |  | + | + | + | + |
 PSWQ-3 |  | + | + | + | + |
 OASIS |  | + | + | + | + |
 PHQ-9 |  | + | + | + | + |
 IUS-12 |  | + | + | + | + |
 CBQ |  | + | + | + | + |
 CPQ |  | + | + | + | + |
 CGI |  | + | + | + | + |
 SDS |  | + | + | + | + |
Process/acceptability measures |
 WAI-SF |  |  | + | + |  |
 CSQ |  |  | + | + |  |
 AQ |  |  | + | + |  |
- Note. DIAMOND Diagnostic Interview for Anxiety, Mood, and Obsessive-Compulsive and Related Neuropsychiatric Disorders, C-SSRS C-Suicide Severity Rating Scale, GAD-7 Generalized Anxiety Scale-7 item, GAD-D Generalized Anxiety Disorder Dimensional Scale, PSWQ-3 Penn State Worry Questionnaire-3 item, OASIS Overall Anxiety Severity and Impairment Scale, PHQ-9 Patient Health Questionnaire-9 item, IUS-12 Intolerance of Uncertainty Scale-12 item, CBQ Core Beliefs Questionnaire, CPQ Clinical Perfectionism Questionnaire, CGI NIMH Clinician Global Impression Scale (self-report version), SDS Sheehan Disability Scale, WAI-SF Working Alliance Inventory-Short Form, CSQ Client Satisfaction Questionnaire, AQ Acceptability Questionnaire